These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 1847588)
1. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle. Guijarro LG; Rodriguez-Pena MS; Prieto JC Am J Physiol; 1991 Feb; 260(2 Pt 1):E286-91. PubMed ID: 1847588 [TBL] [Abstract][Full Text] [Related]
2. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes. Provow S; Veliçelebi G Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591 [TBL] [Abstract][Full Text] [Related]
3. Characteristics of receptors for VIP in rat peritoneal macrophage membranes. Calvo JR; Guerrero JM; López-Gonzalez MA; Osuna C; Segura JJ Peptides; 1994; 15(2):309-15. PubMed ID: 8008637 [TBL] [Abstract][Full Text] [Related]
4. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein. Couvineau A; Amiranoff B; Laburthe M J Biol Chem; 1986 Nov; 261(31):14482-9. PubMed ID: 3021741 [TBL] [Abstract][Full Text] [Related]
5. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas. Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591 [TBL] [Abstract][Full Text] [Related]
6. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium. Elgavish A; Pillion DJ; Meezan E Life Sci; 1989; 44(15):1037-42. PubMed ID: 2538697 [TBL] [Abstract][Full Text] [Related]
7. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages. Sakakibara H; Shima K; Said SI Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells. Gespach C; Bawab W; de Cremoux P; Calvo F Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044 [TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Couvineau A; Gammeltoft S; Laburthe M J Neurochem; 1986 Nov; 47(5):1469-75. PubMed ID: 3020175 [TBL] [Abstract][Full Text] [Related]
10. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung. Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS Peptides; 1986; 7(5):791-800. PubMed ID: 3025822 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium. Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439 [TBL] [Abstract][Full Text] [Related]
12. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29. Couvineau A; Rousset M; Laburthe M Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337 [TBL] [Abstract][Full Text] [Related]
13. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170 [TBL] [Abstract][Full Text] [Related]
14. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors. Patthi S; Simerson S; Veliçelebi G J Biol Chem; 1988 Dec; 263(36):19363-9. PubMed ID: 2848823 [TBL] [Abstract][Full Text] [Related]
15. Solubilization and hydrodynamic characterization of guanine nucleotide sensitive vasoactive intestinal peptide-receptor complexes from rat intestine. Calvo JR; Couvineau A; Guijarro L; Laburthe M Biochemistry; 1989 Feb; 28(4):1667-72. PubMed ID: 2541761 [TBL] [Abstract][Full Text] [Related]
16. VIP receptor-effector system in rat harderian gland and its coupling to activation of type II thyroxine 5'-deiodinase. Calvo JR; Caraballo MI; Pozo D; Segura JJ; Osuna C; Guerrero JM Peptides; 1995; 16(3):551-7. PubMed ID: 7651912 [TBL] [Abstract][Full Text] [Related]
17. Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland. Guerrero JM; Osuna C; Molinero P; Caraballo MI; Harmouch A; Pozo D; Rafii-el-Idrissi M; Garcia-Macias JF; Calvo JR Microsc Res Tech; 1996 Jun; 34(2):139-43. PubMed ID: 8722708 [TBL] [Abstract][Full Text] [Related]
18. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells. el Battari A; Martin JM; Luis J; Pouzol O; Secchi J; Marvaldi J; Pichon J J Biol Chem; 1988 Nov; 263(33):17685-9. PubMed ID: 2846575 [TBL] [Abstract][Full Text] [Related]
19. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver. Guijarro L; Couvineau A; Calvo JR; Laburthe M Regul Pept; 1989 Apr; 25(1):37-50. PubMed ID: 2541470 [TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung. Paul S; Said SI J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]